Phase 3 Readout~month
Phase 3 Topline: A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the Safety, Tolera
- Company
- Vaxcyte, Inc. (PCVX)
- Drug
- immunobridging
- Indication
- Pneumococcal Vaccines
Other upcoming events for PCVX
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.